Whereas c-REL was currently discussed as being mutated in hematopoietic and lymphoid tumors [57], a high throughput database analysis performed in the present study including 3397 hematopoietic and lymphoid tumors detected mutations in only a few samples [35, 58]. This evidence concerns the gene REL and lymphoid neoplasm.